Bone marrow lesions predict progression of cartilage defects and loss of cartilage volume in healthy middle-aged adults without knee pain over 2 yrs

Rheumatology

Volumn 47, Issue 9, 2008, Pages 1392-1396

  Wluka, Anita E ^a,b   Wang, Y ^a   Davies Tuck, M ^a   English, D R ^c,d   Giles, G G ^d   Cicuttini, F M ^a  

^a MONASH UNIVERSITY MEDICAL SCHOOL   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d CANCER EPIDEMIOLOGY CENTRE   (Australia)

Author keywords

Bone marrow lesions; Cartilage; Cartilage defects; Cartilage volume; Osteoarthritis

Indexed keywords

ADULT; AGED; ARTICLE; BONE MARROW DISEASE; CHONDROPATHY; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; IMAGE ANALYSIS; KNEE MENISCUS; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

AGED; ANTHROPOMETRY; BONE MARROW; CARTILAGE, ARTICULAR; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KNEE JOINT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PROSPECTIVE STUDIES;

EID: 50849144043     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken237     Document Type: Article

References (29)

1. Felson DT, Chaisson CE, Hill CL et al. The association of bone marrow lesions with pain in knee osteoarthritis. Ann Intern Med 2001;134:541-9.
2. Felson DT, Niu J, Guermazi A et al. Correlation of the development of knee pain with enlarging bone marrow lesions on magnetic resonance imaging. Arthritis Rheum 2007;56:2986-92.
3. Garnero P, Peterfy C, Zaim S, Schoenharting M. Bone marrow abnormalities on magnetic resonance imaging are associated with type II collagen degradation in knee osteoarthritis: A three-month longitudinal study. Arthritis Rheum 2005;52:2822-9.
4. Hunter DJ, Zhang Y, Niu J et al. Increase in bone marrow lesions associated with cartilage loss: A longitudinal magnetic resonance imaging study of knee osteoarthritis. Arthritis Rheum 2006;54:1529-35.
5. Baranyay FJ, Wang Y, Wluka AE, English DR et al. Association of bone marrow lesions with knee structures and risk factors for bone marrow lesions in the knees of clinically healthy, community-based adults. Semin Arthritis Rheum 2007;37:112-8.
6. Guymer E, Baranyay FJ, Wluka AE et al. Risk factors and significance of subchondral bone marrow lesions in the knees of healthy middle-aged women. Osteoarthr Cartil 2007;15:1437-42.
7. Jones G, Ding C, Scott F, Glisson M, Cicuttini FM. Early radiographic osteoarthritis is associated with substantial changes in cartilage volume and tibial bone surface area in both males and females. Osteoarthr Cartil 2003;12:169-74.
8. Cicuttini FM, Wluka AE, Wolfe R, Forbes A. Comparison of tibial cartilage volume and radiologic grade of the tibiofemoral joint. Arthritis Rheum 2003;48:682-8.
9. Cicuttini FM, Ding C, Wluka AE, Davis SR, Ebeling PR, Jones G. Association of cartilage defects with loss of knee cartilage in healthy, middle-age adults: A prospective study. Arthritis Rheum 2005;52:2033-9.
10. Wang Y, Ding C, Wluka AE et al. Factors affecting progression of knee cartilage defects in normal subjects over 2 years. Rheumatology 2006;45:79-84.
11. Wluka AE, Wolfe R, Davis SR, Stuckey S, Cicuttini FM. Tibial cartilage volume change in healthy postmenopausal women: A longitudinal study. Ann Rheum Dis 2004;63:444-9.
12. Wluka AE, Wolfe R, Stuckey SL, Cicuttini FM. How does tibial cartilage volume relate to symptoms in subjects with knee osteoarthritis? Ann Rheum Dis 2004;63:264-8.
13. Cicuttini FM, Jones G, Forbes A, Wluka AE. Rate of cartilage loss at two years predicts subsequent total knee arthroplasty: A prospective study. Ann Rheum Dis 2004;63:1124-7.
14. Wluka AE, Ding C, Jones G, Cicuttini FM. The clinical correlates of articular cartilage defects in symptomatic knee osteoarthritis: A prospective study. Rheumatology 2005;44:1311-6.
15. Giles GG, English DR. The Melbourne Collaborative Cohort Study. IARC Sci Publ 2002;156:69-70.
16. Wang Y, Wluka AE, English DR et al. Body composition and knee cartilage properties in healthy, community-based adults. Ann Rheum Dis 2007;66:1244-8.
17. Altman R, Asch E, Bloch D et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986;29:1039-49.
18. Hanna FS, Bell RJ, Davis SR et al. Factors affecting patella cartilage and bone in middle-aged women. Arthritis Rheum 2007;57:272-8.
19. McAlindon T, Watt I, McCrae F, Goddard P, Dieppe PA. Magnetic resonance imaging in osteoarthritis of the knee: Correlation with radiographic and scintigraphic findings. Ann Rheum Dis 1991;50:14-9.
20. Felson DT, McLaughlin S, Goggins J et al. Bone marrow edema and its relation to progression of knee osteoarthritis. Ann Intern Med 2003;139:330-6.
21. Ding C, Cicuttini F, Scott F, Boon C, Jones G. Association of prevalent and incident knee cartilage defects with loss of tibial and patellar cartilage: A longitudinal study. Arthritis Rheum 2005;52:3918-27.
22. Ding C, Garnero P, Cicuttini FM, Scott F, Cooley H, Jones G. Knee cartilage defects: Association with early radiographic osteoarthritis, decreased cartilage volume, increased joint surface area and type II collagen breakdown. Osteoarthr Cartil 2005;13:198-205.
23. Wluka AE, Stuckey S, Snaddon J, Cicuttini FM. The determinants of change in tibial cartilage volume in osteoarthritic knees. Arthritis Rheum 2002;46:2065-72.
24. Jackson BD, Teichtahl AJ, Morris ME, Wluka AE, Davis SR, Cicuttini FM. The effect of the knee adduction moment on tibial cartilage volume and bone size in healthy women. Rheumatology 2004;43:311-4.
25. Wluka AE, Stuckey SL, Brand C, Cicuttini FM. Supplementary vitamin E does not affect the loss of cartilage volume in knee osteoarthritis: A 2 year double-blind randomised placebo controlled study. J Rheumatol 2002;29:2585-91.
26. Clegg DO, Reda DJ, Harris CL et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis [see comment]. N Engl J Med 2006;354:795-808.
27. Carbone LD, Nevitt MC, Wildy K et al. The relationship of antiresorptive drug use to structural findings and symptoms of knee osteoarthritis. Arthritis Rheum 2004;50:3516-25.
28. Bingham CO III, Buckland-Wright C, Garnero P et al. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: Results of the two-year Multinational Knee Osteoarthritis Structural Arthritis Study. Arthritis Rheum 2006;54:3494-507.
29. Buckland-Wright C, Messent EA, Bingham CO III, Ward RJ, Tonkin C. A 2 yr longitudinal radiographic study examining the effect of a bisphosphonate (risedronate) upon subchondral bone loss in osteoarthritic knee patients. Rheumatology 2007;46:257-64.